Mangafodipir
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
Top View
- Known Bioactive Library: Microsource Discovery 1
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Pharmacologyonline 3: 728-781 (2010) Newsletter Bradu and Rossini
- Version 10.3
- To USP 39–NF 34, First Supplement the Following Index Is For
- (12) Patent Application Publication (10) Pub. No.: US 2008/0027082 A1 Hocher Et Al
- August 2019 Volume 40 • Pp 1251–1436
- A Serial Dilution Study of Gadolinium-Based MR Imaging
- Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma Comparative Effectiveness Review Number 141
- Contrast Dye Poster Back3
- Targeted Contrast Agent for Magnetic Resonance Imaging Based on Mn/H- Ferritin Nanocomplexes
- To USP 39–NF 34, Second Supplement the Following Index Is
- Ioxilan (USAN, Rinn) C12h10i3n2nao5 = 665.9
- (12) United States Patent (10) Patent No.: US 8,802,596 B2 Rogers Et Al
- 12 MR Contrast Agents
- [Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
- MRI Contrast Agents: Classification and Application (Review)